Literature DB >> 11162310

Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle.

M L Lucas1, R Heller.   

Abstract

Recent reports have shown the successful delivery of plasmid DNA to skeletal muscle by in vivo electroporation. However, most of these reports have used what has been characterized as low-voltage, millisecond pulses. One of the purposes of this study was to examine a wide range of parameters to establish a better understanding of the effects of field strength and pulse length. Two electroporation conditions, one utilizing low-voltage millisecond pulses and the other high-voltage microsecond pulses, were compared for their ability to deliver a molecule that can be measured systemically, IL-12. Not only was this molecule efficiently delivered, but one of the molecules it induces (IFN-gamma) was also measured systemically, with expression peaking at greater than 200 pg/ml serum levels on day 7 and still as high as 40 pg/ml on day 21 when using electrical parameters of 100 V/cm, 20-ms pulses. Of the two types of parameters tested, low-voltage, millisecond pulses resulted in higher, prolonged expression of plasmid DNA than high-voltage, microsecond pulses. In summary, this report provides evidence that in vivo electroporation is an efficient method for the delivery of plasmid DNA, and its use in immunotherapy protocols should be furthered examined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162310     DOI: 10.1006/mthe.2000.0233

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  12 in total

1.  Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode.

Authors:  L C Heller; M J Jaroszeski; D Coppola; A N McCray; J Hickey; R Heller
Journal:  Gene Ther       Date:  2006-09-21       Impact factor: 5.250

2.  Transfection by electroporation.

Authors:  Huntington Potter
Journal:  Curr Protoc Mol Biol       Date:  2003-05

3.  The use of an in vitro 3D melanoma model to predict in vivo plasmid transfection using electroporation.

Authors:  Bernadette Marrero; Richard Heller
Journal:  Biomaterials       Date:  2012-01-13       Impact factor: 12.479

4.  Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma.

Authors:  Richard J Connolly; Jose I Rey; Vance M Lambert; Garrett Wegerif; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Vaccine       Date:  2010-12-31       Impact factor: 3.641

5.  Gene delivery in adherent and suspension cells using the combined physical methods.

Authors:  Kimia Kardani; Alireza Milani; Azam Bolhassani
Journal:  Cytotechnology       Date:  2022-02-03       Impact factor: 2.058

6.  Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.

Authors:  W G Marshall; B A Boone; J D Burgos; S I Gografe; M K Baldwin; M L Danielson; M J Larson; D R Caretto; Y Cruz; B Ferraro; L C Heller; K E Ugen; M J Jaroszeski; R Heller
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

7.  Muscle gene electrotransfer is increased by the antioxidant tempol in mice.

Authors:  B Markelc; G Tevz; M Cemazar; S Kranjc; J Lavrencak; B Zegura; J Teissie; G Sersa
Journal:  Gene Ther       Date:  2011-06-30       Impact factor: 5.250

8.  Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis.

Authors:  I-Chuan Chuang; Chien-Ming Jhao; Chih-Hsun Yang; Hsien-Chang Chang; Chien-Wen Wang; Cheng-Yuan Lu; Yao-Jen Chang; Sheng-Han Lin; Pao-Lin Huang; Lin-Cheng Yang
Journal:  Arthritis Res Ther       Date:  2003-10-17       Impact factor: 5.156

9.  Delivery of interleukin-15 to B16 melanoma by electroporation leads to tumor regression and long-term survival.

Authors:  Bernadette Marrero; Shawna Shirley; Richard Heller
Journal:  Technol Cancer Res Treat       Date:  2013-08-31

10.  Gene expression profiles in skeletal muscle after gene electrotransfer.

Authors:  Pernille Hojman; John R Zibert; Hanne Gissel; Jens Eriksen; Julie Gehl
Journal:  BMC Mol Biol       Date:  2007-06-29       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.